Table 4.
Clinical features of patients of AIPD (n = 29) according to the specific diagnostic categories.
| N | Alu Median (interquartile range) (ng/ml) | P-value | |
|---|---|---|---|
| Total | 29 | 315.3 (148.5–462.9) | |
| Gender | – | ||
| Male | 29 (100%) | 315.3 (148.5–462.9) | |
| Female | 0 (0%) | 0 | |
| Psychosis onset age (y) | 0.8399 | ||
| Up to 35 | 5 (17.2%) | 151.8 (135.8–462.9) | |
| 36 or more | 24 (82.8%) | 336.2 (150–486.6) | |
| Current age (y) | 0.9714 | ||
| 30 to 35 | 3 (10.3%) | 151.8 (143.8–454.9) | |
| 36 or more | 26 (89.7%) | 336.2 (149.08–461.7) | |
| Duration of psychosis (in weeks) | 0.4785 | ||
| Up to 52 | 9 (31.0%) | 151.8 (143.4–322.5) | |
| 53 or more | 20 (69.0%) | 283.2 (148.3–461.7) | |
| Pharmacological treatment (in weeks) | 0.7513 | ||
| Up to 4 | 19 (65.5%) | 250.7 (147.5–458.0) | |
| 5 or more | 10 (34.5%) | 251.0 (139.4–347.7) | |
| Current treatment | 0.2175 | ||
| AP+AD | 25 (86.2%) | 251.0 (148.5–416.5) | |
| AP+AD+MS | 4 (13.8%) | 531.4 (379.2–926.7) | |
| Family history | – | ||
| Yes | 0 (0%) | – | |
| No | 29 (100%) | 315.3 (148.5–462.9) |
AIPD, alcohol-induced psychotic disorder; AP, anti-psychotics; AD, antidepressants; MS, mood stabilizers.
P < 0.05 was considered statistically significant.